Stuttgart - Delayed Quote EUR

Novavax Inc (NVV1.SG)

5.28
-0.82
(-13.43%)
At close: May 9 at 9:32:44 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
682,162
682,162
556,382
1,598,951
197,581
Cost of Revenue
202,739
202,739
343,768
902,639
0
Gross Profit
479,423
479,423
212,614
696,312
197,581
Operating Expense
728,354
728,354
779,125
1,341,048
1,884,157
Operating Income
-248,931
-248,931
-566,511
-644,736
-1,686,576
Net Non Operating Interest Income Expense
-20,075
-20,075
-14,416
-19,880
-21,127
Other Income Expense
92,391
92,391
37,896
10,969
-6,833
Pretax Income
-176,615
-176,615
-543,031
-653,647
-1,714,536
Tax Provision
10,884
10,884
2,031
4,292
29,215
Net Income Common Stockholders
-187,499
-187,499
-545,062
-657,939
-1,743,751
Diluted NI Available to Com Stockholders
-187,499
-187,499
-545,062
-657,939
-1,743,751
Basic EPS
-1.23
-1.23
-5.41
-8.42
-23.44
Diluted EPS
-1.23
-1.23
-5.41
-8.42
-23.44
Basic Average Shares
152,190
152,190
100,768
78,183
74,400
Diluted Average Shares
152,190
152,190
100,768
78,183
74,400
Total Operating Income as Reported
-248,931
-248,931
-566,511
-644,736
-1,686,576
Total Expenses
931,093
931,093
1,122,893
2,243,687
1,884,157
Net Income from Continuing & Discontinued Operation
-187,499
-187,499
-545,062
-657,939
-1,743,751
Normalized Income
-228,538.71
-228,538.71
-545,062
-657,939
-1,743,751
Interest Expense
20,075
20,075
14,416
19,880
21,127
Net Interest Income
-20,075
-20,075
-14,416
-19,880
-21,127
EBIT
-156,540
-156,540
-528,615
-633,767
-1,693,409
EBITDA
-108,044
-108,044
-487,390
-604,713
-1,680,748
Reconciled Cost of Revenue
202,739
202,739
343,768
902,639
0
Reconciled Depreciation
48,496
48,496
41,225
29,054
12,661
Net Income from Continuing Operation Net Minority Interest
-187,499
-187,499
-545,062
-657,939
-1,743,751
Total Unusual Items Excluding Goodwill
51,949
51,949
0
0
1,364
Total Unusual Items
51,949
51,949
0
0
1,364
Normalized EBITDA
-159,993
-159,993
-487,390
-604,713
-1,680,748
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
10,909.29
10,909.29
0
0
0
12/31/2021 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

22UA.BE BioNTech SE
85.25
+0.41%
 
BNTX.VI BioNTech SE
83.20
-0.42%
 
22UA.MU BioNTech SE
84.85
+0.83%
 
22UA.DU BioNTech SE
82.90
-2.36%
 
0QF.DE Moderna, Inc.
22.09
+2.63%
 
22UA.DE BioNTech SE
83.35
-0.71%
 
RAPT RAPT Therapeutics, Inc.
0.7535
-5.81%
 
ZBIO Zenas BioPharma, Inc.
9.05
-2.58%
 
IPA ImmunoPrecise Antibodies Ltd.
0.4489
-1.88%
 
ACRS Aclaris Therapeutics, Inc.
1.2600
-3.82%